RECRUITING

Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a randomized, parallel-group study designed to explore the differences between cannabis intoxication, alcohol intoxication and co-intoxication involving both alcohol and cannabis, utilizing electroencephalography (EEG) as well as more traditional intoxication measures such as breath alcohol concentration and balance metrics. If eligible for the study, participants will be randomized to complete one study session in our mobile laboratory, during which they will use either alcohol, cannabis (which will be self-administered, ad libitum) or both alcohol and cannabis.

Official Title

Developing Predictive Models to Distinguish Alcohol Use, Cannabis Use and Co-use: An Exploration of Electroencephalography (EEG) Metrics and Traditional Intoxication Measures

Quick Facts

Study Start:2024-01-05
Study Completion:2026-05-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06259916

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 50 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * 21-50 years old
  2. * Heavy drinkers (consuming more than 4 drinks/day or more than 14 drinks/week for men, or more than 3 drinks/day or more than 7 drinks/week for women)
  3. * Regular users of legal-market flower cannabis (at least 2x/week in past 3 months)
  4. * report simultaneously using alcohol and legal-market flower cannabis at least once per month in the past 3 months
  5. * English speakers.
  1. * Daily tobacco users
  2. * Diagnosed with or seeking treatment for alcohol use disorder (AUD) or other substance use disorder (SUD)
  3. * Females cannot be pregnant, breastfeeding or trying to become pregnant
  4. * Meet criteria for psychotic, bipolar or major depressive disorder with suicidal ideation, or history of these disorders, 5) Current use of psychotropic (except anti-depressants)
  5. * Report illicit drug use in past 60-days or fail drug screen on the day of the study appointment
  6. * Major medical condition contraindicating alcohol and/or cannabis consumption.

Contacts and Locations

Study Contact

Hollis C Karoly, PhD
CONTACT
970-491-3677
hollis.karoly@colostate.edu
Patricia Davies, PhD
CONTACT
(970) 491-7294
patricia.davies@colostate.edu

Principal Investigator

Hollis Karoly, PhD
PRINCIPAL_INVESTIGATOR
Colorado State University
Patricia Davies, PhD
PRINCIPAL_INVESTIGATOR
Colorado State University

Study Locations (Sites)

Colorado State University
Fort Collins, Colorado, 80523
United States

Collaborators and Investigators

Sponsor: Colorado State University

  • Hollis Karoly, PhD, PRINCIPAL_INVESTIGATOR, Colorado State University
  • Patricia Davies, PhD, PRINCIPAL_INVESTIGATOR, Colorado State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-05
Study Completion Date2026-05-30

Study Record Updates

Study Start Date2024-01-05
Study Completion Date2026-05-30

Terms related to this study

Additional Relevant MeSH Terms

  • Cannabis Use
  • Alcohol Use, Unspecified